Connection

Emil Say to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Emil Say has written about Antibodies, Monoclonal, Humanized.
Emil Say
Connection Strength
0.102
Antibodies, Monoclonal, Humanized
  1. Intravitreal bevacizumab at 4-month intervals for prevention of macular edema after plaque radiotherapy of uveal melanoma. Ophthalmology. 2014 Jan; 121(1):269-275.
    View in: PubMed
    Score: 0.102
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.